At 12:58, the S&P BSE Sensex was 231 points higher at 29,824 levels, while the CNX Nifty gained 58 points to 9,055 levels.
Shares of Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company (SPARC) have touched their respective record high after SPARC announced that the U.S. Food and Drug Administration (FDA) have approved its new drug application (NDA) for ELEPSIA XR (Levetiracetam extended-release tablets 1000 mg and 1500 mg). Sun Pharma is up 10%.
Other notable gainers are ITC, Bharti Airtel, HDFC, ICICI Bank and Tata Motors.
Among losers, Hindalco, Coal India, Tata Power, Wipro and GAIL are down 1-3%.
Government today began the second round of coal mine auctions by putting on offer four blocks - all in Jharkhand - with firms including Adani Power, JSW Steel, SAIL and BALCO in the race.
************************************
Updated at 12:07
Benchmark indices have trimmed gains after hitting record high levels in early trades after RBI’s Raghuram Rajan brought down its key policy rate by 25 basis points.
At 12.07 PM, the S&P BSE Sensex is 132 points higher at 29,726 levels, while the CNX Nifty has gained 31 points to 9,027 levels. Sensex and Nifty hit their record high levels of 30,025 and 9,119, respectively in the intra-day trades.
The top gainers on the Sensex are Sun Pharma, Bharti Airtel, ICICI Bank, HDFC and Tata Motors.
On the losing side, Hindalco, Coal India, Tata Power, Sesa Sterlite and Axis Bank have fallen between 1-3%.
***********************************
Updated at 11:25
Markets continue to trade firm in the late morning trades after Reserve Bank of India governor Raghuram Rajan on Wednesday brought down its key policy rate by 25 basis points citing that it was convinced by the fiscal consolidation measures announced in the Budget.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)